SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003791
Accepted
2024-12-17 00:15:10
Documents
1
Effectiveness Date
2024-12-16
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 584
  Complete submission text file 9999999995-24-003791.txt   2030
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-283561 | Film No.: 241553497
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)